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Abstract
Cholesterol is the major sterol component of all mammalian cell plasma membranes and plays a critical role in cell function
and growth. Previous studies have shown that cholesterol inhibits inward rectifier K
+ (Kir) channels, but have not
distinguished whether this is due directly to protein-sterol interactions or indirectly to changes in the physical properties of
the lipid bilayer. Using purified bacterial and eukaryotic Kir channels reconstituted into liposomes of controlled lipid
composition, we demonstrate by
86Rb
+ influx assays that bacterial Kir channels (KirBac1.1 and KirBac3.1) and human Kir2.1
are all inhibited by cholesterol, most likely by locking the channels into prolonged closed states, whereas the enantiomer,
ent-cholesterol, does not inhibit these channels. These data indicate that cholesterol regulates Kir channels through direct
protein-sterol interactions likely taking advantage of an evolutionarily conserved binding pocket.
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Introduction
Cholesterol is the major sterol component of all mammalian cell
plasma membranes and plays a critical role in cell function and
growth. Excess cholesterol is cytotoxic [1–3] resulting in changes
in the function of various membrane proteins, including potassium
(K
+) channels [4–8], voltage-gated calcium (Cav) channels [9–13],
voltage-gated sodium (Nav) channels [14,15], and chloride (Cl
2)
channels [16,17]. Kir channels are expressed in a wide variety of
cells including skeletal, cardiac, and vascular myocytes, neurons,
and pancreatic b-cells and play numerous key physiological roles
including stabilizing the resting membrane potential, regulating
K
+ ion flux across cellular membranes, and regulation of cellular
excitability [18]. Previous studies have identified cholesterol
suppression of inward rectifier K
+ channels (‘‘Kir’’ or ‘‘KCNJ’’
channels) in aortic endothelial cells [8] and by heterologous
expression in chinese hamster ovary (CHO) cells [7,19,20].
The mechanism by which cholesterol regulates Kir channels has
remained elusive since, until recently, experiments could only be
done in cell lines where membrane lipid compositions are
undefined, difficult to manipulate quantitatively and can vary
dramatically from cell to cell and with time. While the reduced
inhibitory effect of the C3-diastereomer, epi-cholesterol, on
KirBac1.1 activity is suggestive that cholesterol inhibition may
be mediated by direct interactions [8,21], epi-cholesterol and
cholesterol orient differently in membranes and may alter
membrane properties differently [22,23]. Thus, changes in Kir
channel function due to changes in the physical properties of the
lipid bilayer rather than direct binding cannot be excluded based
on previous studies.
We have recently shown that Saccharomyces cerevisiae can be used
to express and purify human Kir channels that can be functionally
reconstituted in artificial membranes of defined composition [24–
26]. In this study, we utilize purified human Kir2.1 channels as
well as two bacterial inward rectifiers (KirBac1.1 and KirBac3.1)
reconstituted into liposomes with or without cholesterol. With the
use of the enantiomeric cholesterol (ent-cholesterol)—which has the
same effects on membrane properties as natural cholesterol [27–
29]—we show that in both the prokaryotic and eukaryotic Kir
channels the effects of cholesterol are due to direct enantioselective
binding of cholesterol to the channel protein, and not an indirect
effect due to changes in lipid bilayer properties. Patch-clamp
analysis suggests that cholesterol may reduce channel activity by
locking the channels into prolonged closed states.
Methods
Human Kir2.1 Protein Purification
A Kir2.1-FLAG-His8 fusion protein (,51.5 kDa per monomer)
was expressed and purified from the FGY217 strain of
Saccharomyces cerevisiae as previously described [24–26].
KirBac1.1 Purification
A KirBac1.1-His6 fusion protein (,38.8 kDa per monomer) was
expressed and purified from the BL21*(DE3) E. coli strain as
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19393previously described [30]. Briefly, cells were grown in 1L cultures
and induced with 0.5 mM IPTG at OD600,1 for 3 hrs at 37uC.
Cells were pelleted and resuspended in 50 mM Tris-HCl pH 8.0,
150 mM KCl, and Complete EDTA-free protease inhibitor tablets
(Roche Diagnostics). Cells were lysed by high pressure (20–25 kpsi)
homogenization using a Microfluidics Cell Disrupter and
solubilized with 30 mM DM for 2 hrs at room temperature.
Following centrifugation at 30,0006 g for 30 mins, the superna-
tant was applied to a cobalt affinity column, washed with 20–
30 column volumes of wash buffer (50 mM Tris pH 8.0, 150 mM
KCl, 10 mM imidazole, and 5 mM DM) and eluted with 1–2 mL
of wash buffer containing 500 mM imidazole.
KirBac3.1 Purification
BL21 CodonPlus RP cells were transformed and grown at 37uC
in a shaker to OD600,0.5 then grown at 19uC until an
OD600,1.0, followed by induction of KirBac3.1 protein
(,33.7 kDa per monomer) expression with 1 mM IPTG. After
16 hours, cells were harvested by centrifugation, the pellet
resuspended in 50 mM Tris-HCl 7.8, 100 mM NaCl, 10 mM
KCl , and Complete EDTA-free protease inhibitor tablets
(Roche). The resuspended cells were passed through a Parr cell
disruptor 5 times, and then centrifuged at 10,000 g for 15 minutes
to remove cell debris. Gycerol (26% v/v final) and decylmaltoside
(37 mM final) were added to the supernatant and rocked at room
tempearture for 3 hours. The mixture was then centrifuged at
10,000 g, for 40 minutes, and the supernatant was mixed with
cobalt affinity beads (Talon) for 2 hours. The beads were washed
in a disposable plastic column with ,20 bed volumes of wash
buffer (50 mm Tris-HCl, pH 8.0, 100 mm NaCl, 10 mM KCl,
2 mM tridecylmaltoside) and eluted with wash buffer containing
400 mm imidazole.
Synthesis of Enantiomeric Cholesterol
ent-cholesterol, the enantiomer of cholesterol, was synthesized as
previously described [31].
86Rb
+ Uptake Assay
POPE (1-palmitoyl-2-oleoyl-3-phosphatidylethanolamine) and
POPG (1-palmitoyl-2-oleoyl-3-phosphatidylglycerol), cholesterol,
and PI(4,5)P2 (phosphatidylinositol 4,5-bisphosphate from porcine
brain) (Avanti Polar Lipids, Inc.) were solubilized in chloroform,
mixed together in the desired concentrations, and dried into a thin
film in glass tubes under a nitrogen stream. These lipids were then
solubilized in buffer A (450 mM KCl, 10 mM HEPES, 4 mM N-
methyl-D-Glucamine, pH 7.5) with 35 mM CHAPS at 10 mg/
ml, mixed at the desired mass ratio, and incubated at room
temperature for 2 h. Thus, when required, cholesterol was
included in the liposomes at the time of formation. Polystyrene
columns (Pierce Chemical Co.) were packed with Sephadex G-50
beads, presoaked overnight in buffer A, and spun on a Beckman
TJ6 centrifuge until reaching 3,000 rpm. For each sample, 3 mgo f
protein was added to 100 ml of lipid (1 mg) and incubated for
30 min. Proteo-liposomes were formed by adding the protein/
lipid sample to the partially dehydrated columns and centrifuging
to 2,500 rpm [24,25,32,33]. The extra-liposomal solution was
exchanged by centrifuging the liposomes to 2,500 rpm in partially-
dehydrated columns, now containing beads soaked in buffer B
(400 mM sorbitol, 10 mM HEPES, 4 mM NMG, pH 7.5).
86Rb
+
uptake was initiated by adding 400 ml of buffer B containing
86Rb
+. At various time points, aliquots of the liposome uptake
reaction were flowed through 0.5 ml Dowex cation exchange
columns in the NMGH
+ form to remove extraliposomal
86Rb
+.
These aliquots were then mixed with scintillation fluid and
counted in a liquid scintillation counter. Valinomycin was used to
measure maximal
86Rb
+ uptake. Data were subtracted from
uptake counts measured at each time point from protein-free
liposomes, and plotted relative to valinomycin-induced uptake
counts.
Electrophysiology of human Kir2.1 in Giant Liposomes
Giant liposomes were prepared in a similar manner as previously
described for KirBac1.1 [32]. Briefly, POPE, POPG and PI(4,5)P2
were solubilized in K-MOPS buffer (10 mM MOPS acid, pH 7.4,
150 mM KCl) and 35 mM CHAPS and mixed at a 3:1:0.04ratio (a
total of 2 mg). Polystyrene columns (Pierce Chemical Co.) were
packed with Sephadex G-50 beads, presoaked overnight in K-
MOPS buffer, and spun on a Beckman TJ6 centrifuge until
reaching 3,000 rpm. Purified Kir2.1 protein was added to the lipids
at lipid to protein mass ratio of 33:1 and incubated at room
temperature for 30 min. Proteo-liposomes were formed by adding
the protein/lipid sample to the partially-dehydrated columns and
spinning to 2,500 rpm, and centrifuged at 100,000 g for 1 h at 4uC
(TL-100; Beckman Coulter). The liposome pellet was resuspended
in 2–3 ml K-MOPS buffer and dried in a desiccator as 2 ml spots on
a clean microscope slide for ,1 h or until completely dried. These
spots were then rehydrated with 20 ml K-MOPS buffer overnight at
4uC. Rehydration at room temperature for ,2 h the next day was
sufficient to form giant liposomes.
For patch-clamp, the giant proteo-liposomes were pipetted onto
a glass cover slip in an oil-gate chamber [34] and allowed to settle
for ,5 min before starting the solution exchange to wash away
debris. Patch-clamp recordings were performed in symmetrical
conditions of K-MOPS buffer. Membrane patches were voltage-
clamped using a CV-4 headstage, an Axopatch 1-D amplifier, and
a Digidata 1322A digitizer board (MDS Analytical Technologies).
Patch pipettes were pulled from soda lime glass microhematocrit
tubes (Kimble) to a resistance of ,1–3 MV. Single-channel data
were digitized at a sampling rate of 10 kHz, and a low-pass
analogue filter was set to 1 kHz. Single-channel amplitude
histograms were performed using the pClamp 9.2 software suite
(MDS Analytical Technologies). The remaining data analysis was
performed using Origin7.0 (Microcal).
Confocal Microscopy
Giant liposomes were formed as above, in the presence or
absence of 5% NBD-cholesterol (chemical nomenclature: 22-(N-
(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-bisnor-5-cholen-
3b-ol) (Invitrogen). Confocal microscopy was performed using a
Zeiss LSM5 Pascal confocal microscope (Zeiss Microimaging,
ThornwooD, NY) with a H106/0.3 Plan-NeoFluar lens (Zeiss).
Fluorescence was excited using 488 nm Argon laser line (Lasos,
Jena, Germany) and emission was collected using a 505 LP filter
(Chroma, Brattleboro, VT). Simultaneously, we collected trans-
mitted light images. Image acquisition and analysis was carried out
using Zeiss AIM software.
Statistical Analysis
Statistical significance was analyzed using an unpaired T-test or
one-way ANOVA with Tukey post-hoc analysis as appropriate,
and statistical significance (P,0.05) is indicated by an asterisk.
Results
Cholesterol Inhibits Purified Prokaryotic and Eukaryotic
Inward Rectifier K
+ Channels
Bacterial inwardly rectifying K
+ channels (KirBac1.1 and
KirBac3.1) were expressed and purified from E. coli, while human
Cholesterol Directly Regulates Kirs
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incorporating these channels into liposomes, previous studies have
shown that these proteins form functional K
+ channels [24–
26,30,32,35], and that KirBac1.1-mediated
86Rb
+ flux is readily
suppressed by the addition of cholesterol to 9:1 POPE:POPG
liposomes [21]. Here we confirm these results (Fig. 1A and B). In
addition, we also show that both KirBac3.1 and human Kir2.1
channel activity are suppressed in liposomes containing as little as
1% cholesterol (mg/mg total lipids) (Fig. 1A and B). Inhibition of
channel activity increased in a concentration-dependent manner
(Fig. 1B). Notably, cholesterol could not be incorporated into
liposomes at concentrations higher than 10%, as indicated by the
formation of a heavy precipitate. Interestingly, in this assay, the
levels of cholesterol which have an inhibitory effect on Kir
channels are well below those typically found in plasma
membranes of mammalian cells (between 30–50% of total
membrane lipids [2,3]). However, the degree of inhibition is
similar to that previously reported for KirBac1.1 [21]. Important-
ly, these results show that regulation of Kir channels does not
require an intermediary protein that is sensitive to cholesterol.
We previously showed that Kir2.1 channels require anionic
phospholipids in addition to PI(4,5)P2 for channel activity [24].
Conceivably cholesterol may compete directly or allosterically with
POPG to reduce channel activity. Thus, cholesterol inhibition of
Kir2.1 and KirBac1.1 channels was also assessed by
86Rb
+ flux in
liposomes containing elevated (25%) POPG (Fig. 1C). This does
not appear to be the mechanism for cholesterol inhibition, since
cholesterol still inhibited KirBac1.1 or Kir2.1 channels in proteo-
liposomes containing 25% POPG (Fig. 1C) similarly to channels in
proteo-liposomes containing only 10% POPG.
Cholesterol Does Not Alter Measurable Open Probability
or Unitary Conductance in Kir2.1
To examine what property of Kir channel function is affected
by the presence of cholesterol in the membrane, single-channel
recordings were performed by reconstituting human Kir2.1
channels into POPE:POPG giant liposomes containing 1%
PI(4,5)P2 and either 0% or 5% cholesterol (Fig. 2A). We find
empirically that giant liposomes cannot be formed under the 10%
POPG condition used above. Thus, we generated giant liposomes
with higher (25%) POPG on a POPE background for these
experiments (ie. 25% POPG, 1% PI(4,5)P2, 74% POPE or 71%
POPE+5% Cholesterol). In the absence of cholesterol, Kir2.1
channels exhibited a unitary conductance of 36.161.5 pS and a
Popen of 0.3560.01 (n=8 patches each). In giant liposomes
containing 5% cholesterol, no difference was observed in either the
measured unitary conductance (33.962.9 pS; P=0.49) (Fig. 2B)
or Popen (0.3460.02; P=0.68) (Fig. 2C) (n=7). These results
cannot explain the inhibitory effect observed under identical
conditions in flux experiments data, so to ensure that these results
truly reflected single-channel behaviour, and not an inability to
incorporate cholesterol into giant liposomes, we made giant
Figure 1. Cholesterol inhibits activity of reconstituted KirBac1.1, KirBac3.1 and human Kir2.1. (A) Representative time course of
86Rb
+
uptake into 9:1 POPE:POPG liposomes (+1% PI(4,5)P2 for Kir2.1) containing increasing amounts of cholesterol reconstituted (0%=&;1 %=N;5 %=m;
10%=.) with KirBac1.1 (left), KirBac3.1 (middle), or Kir2.1 (right) protein, incubated with 450 mM internal and 0 mM external [K
+]. Uptake was
normalized to valinomycin-induced uptake in the same liposomes. (B) Channel activity-cholesterol relationship obtained from
86Rb
+ uptake at 240 s
for KirBac1.1 (blue; n=76s.e.m), at 90 mins for KirBac3.1 (green; n=66s.e.m) and at 60 mins for human Kir2.1 (red; n=66s.e.m) for each cholesterol
concentration. The data are renormalized to uptake in liposomes containing 0% cholesterol. (C)
86Rb
+ uptake from KirBac1.1 (blue) and Kir2.1 (red)
channels reconstituted into liposomes containing 25% POPG (+1% PI(4,5)P2 for Kir2.1) 65% cholesterol on a POPE background (n=8 for each). The
data were normalized to valinomycin-induced uptake in the same liposomes and re-normalized to uptake in liposomes containing 0% cholesterol.
(* P,0.05 assessed by ANOVA).
doi:10.1371/journal.pone.0019393.g001
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(NBD-cholesterol) (Fig. 3). With excitation by 488 nm light, no
fluorescence was observed from giant liposomes formed in the
absence of cholesterol (Fig. 3 top), but robust fluorescence was
detected from liposomes containing 5% NBD-cholesterol (Fig. 3
bottom), indicating that the patch-clamp experiments are not
limited by the ability to incorporate cholesterol into giant
liposomes.
Thus, our electrophysiological results do in fact reflect Kir2.1
single-channel behaviour, and support the idea that cholesterol
may act to cause long-term ‘‘silencing’’ of channels by inducing
prolonged closed states. One consequence of such a mechanism
would be a reduction in the ‘‘observed’’ average number of
channels in each patch with the inclusion of cholesterol in the
membranes. Although not statistically significant, this appears to
be the trend: we detected 6.761.8 channels per active patch
(range=1–14 channels/patch) in the absence of cholesterol, versus
4.261.8 channels per patch (1–10 channels/active patch) in the
presence of 5% cholesterol (P=0.29; n=7 and n=6 respectively).
Power analysis indicates that for 80% power, data from more than
85 patches would have to be collected to determine if this trend is
significant. Given the cost of protein purifications, and the
variability of the patches, we have not attempted to perform this
number of experiments.
Enantiospecific Binding of Cholesterol to Prokaryotic and
Eukaryotic Inward Rectifier K
+ Channels
Cholesterol can act to alter the function of membrane proteins
either through direct binding or indirectly through changes in
membrane fluidity, stiffness, thickness, permeability and/or
phospholipid packing [2,3,36–41]. To distinguish between these
possible mechanisms for cholesterol effects on Kir channel
function we utilized the enantiomer of cholesterol (ent-cholesterol),
which has the same effects on membrane properties as cholesterol
[27,28,42], yet cannot interact identically with the anisotropic
structure of proteins. By comparing the effect of either 5%
cholesterol or ent-cholesterol on
86Rb
+ uptake we show that the
effect of cholesterol on KirBac1.1, KirBac3.1 and human Kir2.1
channel activity is enantioselective (Fig. 4A and B). This
differential effect of cholesterol and ent-cholesterol on prokaryotic
and eukaryotic inward rectifier K
+ channels implies that in these
channels, cholesterol inhibition depends on enantiospecific
protein-sterol interactions, rather than on indirect changes of the
physical properties of the lipid bilayer.
Discussion
A growing number of ion channels have been shown to be
regulated by components of the lipid membranes [4–
8,10,11,13,19–21], and previous studies have indicated that
cholesterol can inhibit both mammalian and bacterial Kir channel
currents [7,19,20]. Here, we have shown that in POPE/POPG
liposomes, containing prokaryotic KirBac1.1, KirBac3.1 or
human Kir2.1 are similarly modulated by as little as 1%
cholesterol (mg/mg total lipids). This is in stark contrast to the
opposing effects of PI(4,5)P2 on prokaryotic and eukaryotic Kirs
[25,35]. Interestingly, the levels of cholesterol necessary to regulate
Kir2.1 channels are well below the levels reported in plasma
membranes of mammalian cells, which range between 30–50% of
total membrane lipids [2,3].
Effects of sterols on lipid membrane properties generally show
no entantioselectivity. In particular, no enantioselective effects on
phase-transition properties [42] and lipid packing in monolayers,
and on bilayer properties as measured by calorimetrey, X-ray
diffraction, and neutron density measurements have been reported
between cholesterol and ent-cholesterol [27]. On the other hand,
studies with enzymes and transporters that use cholesterol as a
substrate demonstrate a high entantiomer selectivity of interaction
[43,44], while lipid domain forming peptides have also been
shown to have differential interactions with cholesterol entantio-
mers [42]. Thus, the differential actions of cholesterol versus ent-
Figure 2. Cholesterol does not affect Kir2.1 open probability or unitary conductance. (A) Representative single-channel recordings from
human Kir2.1 channels reconstituted into 3:1 POPE:POPG giant liposomes at 2100 mV in the absence (left) or presence (right) of 5% cholesterol.
Neither the unitary conductance (i) – voltage (V) relationships (B; P=0.49, n=8) nor open probability (C; P=0.68, n=7) were significantly different for
human Kir2.1 channels reconstituted into liposomes containing 0% (&)o r5 %( %) cholesterol.
doi:10.1371/journal.pone.0019393.g002
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protein-sterol interactions [27–29].
Previous studies have attempted to address whether the
regulation of Kir channel function results from direct channel-
sterol interactions or indirect effects such as changes to the
physical properties of the lipid bilayer or regulation by an
intermediary cholesterol-sensitive protein through the use of the
C3-diastereomer, epi-cholesterol [8,21]. Epi-cholesterol inhibited
KirBac1.1 channels less than the equivalent amount of choles-
terol [8,21]. Partial substitution of cholesterol with epi-cholesterol
in mammalian cells resulted in an increase in current relative to
control, which may suggest specific protein-sterol interactions
[8,21]. However, the interpretation of such studies is not trivial
since (a) mediation through accessory proteins cannot be
excluded from recordings done in eukaryotic cell membranes
and (b) epi- and natural cholesterol orient differently in
membranes, and can thus alter membrane properties differently
[22,23]. No enantioselectivity has been observed for cholesterol
effects on various lipid bilayer and monolayer properties [27,28].
Thus, determining the enantioselectivity of purified channel
regulation by cholesterol with the use of ent-cholesterol is a more
suitable approach. This assay has been used to determine the
enantioselectivity of cholesterol regulation of numerous channels
and receptors (for complete list see review by Covey, 2009 [45]),
including a recent study of calcium-activated BK channels [46].
Using this assay, we observed that both prokaryotic and
eukaryotic Kir channels are indeed enantioselective for choles-
terol, indicating that modulation by this sterol is mediated by
direct binding to the channel. Since the degree of channel
modulation by cholesterol is similar between prokaryotic and
eukaryotic Kir channels and since cholesterol is not present in
prokaryotic membranes [47], we speculate that modulation of
eukaryotic Kirs by cholesterol utilizes a conserved ‘‘binding
pocket’’ also found in prokaryotic Kirs. It has been previously
suggested that cholesterol may bind to Kir channels in a
confirmation that requires the cytoplasmic domain to be close
to the membrane [48] and that this confirmation may be favored
when residue 222 in Kir2.1 channels is a leucine, and
unfavourable when isoleucine [48]. Although KirBac channels
do not have leucine at the equivalent position, comparison of the
eukaryotic and bacterial channel structures indicates that the
cytoplasmic domains of KirBac channels are already closer to the
Figure 3. Cholesterol is present in giant liposomes. Giant liposomes were made with 3:1 POPE:POPG and 0% or 5% NBD-Cholesterol. Giant
liposomes formed without NBD-cholesterol showed no emission above 505 nm following excitation at 488 nm. Robust fluorescence was observed
for giant liposomes made in the presence of 5% NBD-cholesterol.
doi:10.1371/journal.pone.0019393.g003
Figure 4. Cholesterol enantiospecifically binds prokaryotic and eukaryotic Kir channels. (A) Representative time course of
86Rb
+ uptake
into 9:1 POPE:POPG liposomes (+1% PI(4,5)P2 for Kir2.1) containing 0% cholesterol (&), 5% cholesterol (N)o r5 %ent-cholesterol (m) reconstituted
with KirBac1.1 (left), KirBac3.1 (middle), or Kir2.1 (right) protein, with 450 mM internal and 0 mM external [K
+]. (B) KirBac1.1 (blue), KirBac3.1 (green)
and human Kir2.1 (red) channel activity-cholesterol relationship obtained from
86Rb
+ uptake counts. The data are renormalized to uptake in
liposomes containing 0% cholesterol. (n=6 for each protein, * P,0.05 assessed by ANOVA).
doi:10.1371/journal.pone.0019393.g004
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c l o s ee n o u g ht oi n t e r a c tw i t hc h o l e s t e r o l .
Unitary conductances and open probabilities were not signif-
icantly different for human Kir2.1 in the presence or absence of
cholesterol in liposomes containing 25% POPG. The presence of
cholesterol in giant liposomes under these conditions was verified
using fluorescent NBD-cholesterol (Fig. 3). Similarly, despite
decreases in whole-cell currents, no changes in single-channel
properties were reported for either IK1 in bovine aortic endothelial
cells or for Kir2.1 currents over-expressed in CHO cells treated
with MbCD-cholesterol [7,8]. We show that increasing POPG
concentration does not alter cholesterol inhibition of Kir2.1 or
KirBac1.1 channels (Fig. 1C), and thus cannot account for the
discrepancy between flux experiments where cholesterol reduced
channel activity by ,45% (Fig. 1) and our patch clamp
experiments on giant liposomes where no effect on channel
conductance or Popen were observed (Fig. 2). Together with our
observation that cholesterol binds directly to Kir channels, these
data support the idea that when bound, cholesterol induces
conformational changes that lead to a prolonged closed state that
cannot be detected by single-channel analysis [7]. Consequently,
we are only able to detect single-channel currents from proteins
not interacting with cholesterol.
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